TREM2 and Alzheimer disease: In human AD, and the APP-PS1 mouse model of AD, they demonstrated the APOE pathway, driven by TREM2, mediated a switch in microglial phenotypes from homeostatic to neurodegenerative, indicating activation of the TREM2-APOE pathway leads to the inability of microglia to regulate brain homeostasis34.